R. Berger

发表

Permeation Studies In Vitro and In Vivo of Potential Radiopharmaceuticals with Affinity to Neuro Receptors

M. Friebe, S. Krämer, E. Chiotellis, 2000, Pharmaceutical Research.

'3+1' mixed-ligand oxotechnetium(V) complexes with affinity for melanoma: synthesis and evaluation in vitro and in vivo.

M. Friebe, M. Eisenhut, A. Mahmood, 2000, Journal of medicinal chemistry.

Complex of technetium(V) with 2,3-dimercaptopropansulphonate (Unithiol): preparation and distribution in the rat.

H. Spies, B. Johannsen, M. Kretzschmar, 1979, The International journal of applied radiation and isotopes.

Resolution of racemic acyl‐amino acids‐ 14C by water‐insoluble hog kidney acylase

B. Johannsen, R. Syhre, R. Berger, 1972 .

SYNTHESIS, STRUCTURE, LIPOPHILICITY AND PROTONATION BEHAVIOUR OF MIXED LIGAND RHENIUM CHELATES FUNCTIONALIZED BY AMINE GROUPS

M. Friebe, E. Chiotellis, C. Raptopoulou, 1998 .

Silyl Modification of Biologically Active Compounds. 7. Synthesis, Structure, Physicochemical and Biological Properties of Some Silicon-containing “3+1” Oxorhenium(V) Complexes

E. Lukevics,, J. Popelis, H. Spies, 2002 .

Efficient phase transfer of pertechnetate with bicyclic guanidinium compounds

H. Stephan, H. Spies, B. Johannsen, 1999 .

Unexpected formation of the new oxorhenium (V) complex [ReO(NH(CH2CH2S)2)(SC6H5)] obtained by NC cleavage of the tripodal ligand N(CH2CH2SH)3

M. Glaser, H. Spies, B. Johannsen, 1997 .

Tc and Re chelates of 8alpha-amino-6-methyl-ergoline: synthesis and affinity to the dopamine D2 receptor.

P. Brust, H. Spies, M. Findeisen, 2002, Bioorganic & medicinal chemistry.

Structural modification of receptor-binding technetium-99m complexes in order to improve brain uptake

M. Scheunemann, P. Brust, H. Spies, 1997, European Journal of Nuclear Medicine.

Novel rhenium complexes derived from alpha-tropanol as potential ligands for the dopamine transporter.

P. Brust, H. Spies, B. Johannsen, 1998, Bioorganic & medicinal chemistry.